Navigation Links
Rexin-G Returns to The Big Apple: Clinical Trials for Pancreatic Cancer and Breast Cancer Open in Manhattan
Date:10/29/2008

SAN MARINO, Calif., Oct. 29 /PRNewswire/ -- Epeius Biotechnologies Corporation announced today the expansion of clinical trials using intravenous Rexin-G for pancreatic cancer and breast cancer in Manhattan, New York. Rexin-G is the world's first tumor-targeted genetic medicine that is designed to seek out and destroy both primary tumors and metastatic cancers that have spread throughout the body. Clinical data from on-going studies in Los Angeles, California, indicating dose-dependent tumor control rates and survival benefits with no major toxicity in Rexin-G-treated patients prompted the extension of these clinical trials to the East Coast. Rexin-G has gained orphan drug status from the U.S. FDA for three clinical indications: pancreatic cancer, osteosarcoma and soft tissue sarcoma.

The New York clinical trials will be conducted at the Bruckner Oncology Center in Manhattan, New York with Howard W. Bruckner, M.D. as the Principal Investigator. Dr. Bruckner is a board certified medical oncologist who trained at Yale University School of Medicine and performed research at the NIH with specialists and collaborative groups. Dr. Bruckner is internationally renowned for his work in pancreatic, breast, gastrointestinal, colon, and ovarian cancers and was the first medical oncologist to treat patients with Rexin-G for advanced pancreatic cancer in the United States (Int'l J Oncol 2006). He has served as an Expert Consultant and Safety Monitor for the National Surgical Adjuvant Project for Breast and Bowel Cancers Project (NSABP) sponsored by the National Cancer Institute. For further information concerning these clinical trials in New York, please go to http://www.clinicaltrials.gov and search Epeius-sponsored protocols C07-104 and C07-105.

About Epeius Biotechnologies

Epeius Biotechnologies Corporation is a privately held biopharmaceutical company dedicated to the advancement of genetic
'/>"/>

SOURCE Epeius Biotechnologies Corporation
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related biology technology :

1. Epeius Biotechnologies Lead Product, Rexin-G for Metastatic Cancer, Aptly Highlighted by National Cancer Institute Journal
2. FDA Grants Epeius Biotechnologies Rexin-G a Third Orphan Drug Designation, This Time for the Treatment of Soft Tissue Sarcomas
3. Epeius Biotechnologies Tumor-Targeted Rexin-G Receives FDA Orphan Drug Designation for the Treatment of Osteosarcoma
4. ASCO 2008: Tumor-Targeted Rexin-G Demonstrates Dose-Dependent Anti-Tumor Activity Without Toxicity in Metastatic Pancreatic Cancer
5. MEDICA 2008 Returns in November
6. NanoMedicine Summit Returns to Cleveland, September 25-26
7. Cystic Fibrosis Trial In Children Returns Positive Data
8. PAREXEL Partners with Glenmark to Win the Good Clinical Practice Journal Award for Most Innovative Patient Recruitment Strategy
9. Waters Corporation Gives Boost to Clinical Research Programs at University of Sherbrooke Hospital
10. Parion Sciences and Kainos Medicines Sign Clinical Development Agreement for Novel Dry Mouth Treatment
11. Stallergenes: Launch of a Phase III Clinical Trial in Adults for Oralair(R) Grasses in the United States Operating Income Expected to Remain Stable in 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... 2013 The Formulate Fusion Fabric Display ... sales and marketing teams looking for a fully-functional package for ... as “everything you’ll need to put together a stunning and ... with a number of displays and accessories that can be ... by 20 feet in size. These components vary from kit ...
(Date:5/20/2013)... 2013 Oven Industries Inc. announces a ... The 5R6-900 benchtop controller has many outstanding user-friendly benefits. ... plugged into the wall as a self-contained temperature control ... detail makes the device unique, as well as highly ... controller can also be used universally, which allows the ...
(Date:5/20/2013)... SAN DIEGO , May 20, 2013  Dr. ... the field of nucleic acid research, recently launched a ... Zone In with Zon ( zon.trilinkbiotech.com ), focuses on ... posts include interviews with industry thought leaders, discussions of ... publications and more. Dr. Zon (PhD ...
(Date:5/20/2013)... May 20, 2013 Cempra, Inc. (Nasdaq: ... differentiated antibiotics to meet critical medical needs in ... it presented data at the American Thoracic Society ... demonstrating the antibacterial and enhanced immunomodulatory ... Phase 2 clinical trial in outpatients with community ...
Breaking Biology Technology:GLM Displays Announces All-in-One Formulate Fusion Fabric Display Kit 2New Laboratory Temperature Controller by Oven Industries 2Dr. Gerald 'Jerry' Zon Launches New Blog for TriLink BioTechnologies 2Cempra Presents Post-Phase 2 Analysis of Solithromycin's Efficacy and Safety Results from Patients with Community Acquired Bacterial Pneumonia (CABP) 2
... EAST NORRITON, Pa., Sept. 14, 2011 Tengion, Inc. (NASDAQ: ... announced that Brian Davis, Vice President Finance and Chief Financial ... Life Sciences Conference on Monday, September 19, 2011, at 1:30 ... presentation can be accessed under "Calendar of Events" in the ...
... a new technique that uses a single UV laser pulse ... method that could help scientists study the mechanical forces at ... lasers are a commonly-used tool for cutting into tissue, but ... a time in a series of steps. If the initial ...
... N.C., Sept. 13, 2011 Microban recently conducted ... planktonic and biofilm growth on High Consistency Rubber ... manufacture of urinary catheters.  Urinary infections are a ... current technologies have had limited success in reducing ...
Cached Biology Technology:Tengion to Present at UBS Global Life Sciences Conference 2Microban Medical Silver Antimicrobial Technologies for HCR Silicone Achieve 5 Log Reductions in Bacteria Growth and Prevent Biofilm Formation 2
(Date:5/21/2013)... Royal Philips Electronics (NYSE: PHG, AEX: PHIA) ... ultrasound with Philips, industry leading Live 3D TEE, now ... with available Live 3D TEE and ICE will be ... EuroPCR, official meeting for the European Association of Percutaneous ... launch in 2012, Philips CX50 xMATRIX has been the ...
(Date:5/21/2013)... epigenetic modifications, which alter the way genes function ... be detected in the blood of pregnant women ... to foretell depression in the weeks after giving ... become debilitating. , The findings of the small ... in the journal Molecular Psychiatry . , ...
(Date:5/20/2013)... colistin are also commonly resistant to antimicrobial substances ... study in mBio , the online open-access ... to colistin and host antimicrobials LL-37 and lysozyme, ... could mean that patients with life-threatening multi-drug resistant ... response. Colistin is a last-line drug for treating ...
Breaking Biology News(10 mins):Philips CX50 xMATRIX now offers world-class interventional and diagnostic features on single portable system 2Genetic predictors of postpartum depression uncovered by Hopkins researchers 2Genetic predictors of postpartum depression uncovered by Hopkins researchers 3Resistance to last-line antibiotic makes bacteria resistant to immune system 2Resistance to last-line antibiotic makes bacteria resistant to immune system 3
... to producing more offspring, larger female hyenas outdo their smaller ... which appears in Proceedings of the Royal Society , ... measure spotted hyenas, size. "This is the first study ... on a large carnivore," said MSU graduate student Eli Swanson, ...
... YORK (March 23, 2011)The job of promoting conservation in the ... according to the authors of a new bird guide produced ... Horizonte in Sao Paulo, Brazil., Published in Portuguese and English, ... highlights the bird life of one of the greatest wild ...
... The FASEB Journal ( http://www.faseb.org ) suggests that pregnant mothers ... who are likely to become junk food junkies themselves. According ... high fat and high sugar diet leads to changes in ... does this offer insight into the ever-increasing rate of human ...
Cached Biology News:Larger female hyenas produce more offspring 2WCS releases 'Birds of Brazil' 2WCS releases 'Birds of Brazil' 3'Junk food' moms have 'junk food' babies 2
... anti-viral agent. Inhibits several important steps of angiogenesis ... HUVEC cells. Also reduces intracellular reactive oxygen species ... of endothelial cells. Formula: ... 8 MolWeight: ...
For mRNA Differential Display with three one-base anchored oligo-dT primers and rationally designed arbitrary 13mers. These kits feature the latest generation of isotopic mRNA Differential Display t...
See product name for description....
NATIVE, ENZYME PORCINE TRYPSIN...
Biology Products: